Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Lloyd-Smith Malcolm
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Cadence Pharmaceuticals Inc.
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Chief Integration Officer
Avg. Two Year Performance
No Purchase Track Record
(17%)
Avg. Sale Return
(8%)
Compound
Holdings:
42.34K
shares
Last Three Months: 27-Aug-24 -- 26-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
27-Nov-22 -- 26-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions